Transcatheter Closure of Patent Ductus Arteriosus in infants between 2-10 kg
نویسندگان
چکیده
Objective: The aim of this study was to present our experiences on transcatheter patent ductus arteriosus (PDA) closure with different devices, mostly the Amplatzer Piccolo Occluder, in infants weighing between 2-10 kg. Material and Methods: In study, files 31 patients who underwent PDA December 2019 August 2022 were reviewed retrospectively. Results: Transcatheter performed 31(14 female) mean age 10.7±6.7 months (2-28), weight 6.6±2 kg (3-9.9). median narrowest diameter 2.2 mm (IQR 2-3) length 6 4.75-8). procedural success rate all interventional procedures 88% (30 34). Complications occurred a total four including failure device implantation one patient, post-procedural embolization 2 patients, significant residual shunt patient. None required surgery. 34 procedures, 3 which reintervention, devices used. Twenty-seven (79%) them Occluder. fluoroscopy times 10.5 minutes 7.25-18.5) 40 35-57.5) respectively. duration follow-up 10.3±8.8 (1-32 months). Conclusion: experience, treatment Occluder first choice for appropriate duct anatomy size kg, is safe effective.
منابع مشابه
Transcatheter Closure of Patent Ductus Arteriosus
Background The USCI PDA Umbrella is a device to close patent ductus arteriosus (PDA) by a transcatheter technique. Human clinical trials have shown excellent efficacy in reducing or eliminating the PDA shunt, but concerns remain about the risk of infection with this device. The purpose of this study was to evaluate the risk of infection using an animal model. Methods and Results Susceptibility ...
متن کاملTranscatheter Closure of Patent Ductus Arteriosus
Patent ductus arteriosus (PDA) constitutes 6 to 11% of all congenital heart defects. While surgical ligation and video-assisted, thoracoscopic interruption of PDA are still available, transcatheter occlusion of PDAs has recently assumed a major role in closure of PDA. A large number of devices have been designed and tested both in animal models and human subjects, but only few devices (free and...
متن کاملIntravenous Paracetamol and Patent Ductus Arteriosus Closure
Background: Standard medical treatments for patent ductus arteriosus (PDA) closure are, including indomethacin/ibuprofen and surgical ligation. Nowadays, a new strategy to close PDA is the use of paracetamol. The present study aimed to describe the use of intravenous (IV) paracetamol for PDA closure in neonates who present a contraindication to ibuprofen or ibuprofen failure with no possibility...
متن کاملTranscatheter closure of patent ductus arteriosus.
More than three decades have passed since the introduction of transcatheter devices for closure of patent ductus arteriosus, and many occluders have been made available since then. The ideal requirements of any procedure are a user-friendly technique, optimum success rate, no residual anomaly, minimal morbidity/mortality, and comparability or superiority to the existing conventional modality of...
متن کاملTranscatheter device closure of patent ductus arteriosus.
OBJECTIVE To determine the efficacy, safety and immediate complications encountered during percutaneous device closure of patent ductus arteriosus (PDA). STUDY DESIGN Case series. PLACE AND DURATION OF STUDY Department of Paediatric Cardiology, AFIC/NIHD, Rawalpindi, from January 2005 to December 2010. METHODOLOGY Consecutive 500 patients who underwent attempted transcatheter PDA device c...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Türkiye çocuk hastal?klar? dergisi
سال: 2022
ISSN: ['1307-4490', '2148-3566']
DOI: https://doi.org/10.12956/tchd.1190725